Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
Starling Oncology
STLN
$676M
| $2.77M | ﹤0.01% |
902,809
+180,909
| +25% | +$555K |
2023 Q1
12 quarters
|
|
1702
Alector
ALEC
$232M
| $2.77M | ﹤0.01% |
1,287,691
-255,959
| -17% | -$514K |
2021 Q4
17 quarters
|
|
1703
Vanguard Total International Bond ETF
BNDX
$82.5B
| $2.75M | ﹤0.01% |
+57,322
| New | +$2.78M |
2026 Q1
0 quarters
|
|
1704
Consumer Portfolio Services
CPSS
$205M
| $2.75M | ﹤0.01% |
356,158
-15,400
| -4% | -$129K |
2013 Q2
51 quarters
|
|
1705
Designer Brands
DBI
$291M
| $2.75M | ﹤0.01% |
483,436
+208,636
| +76% | +$1.4M |
2025 Q4
1 quarter
|
|
1706
First Bancorp
FNLC
$372M
| $2.75M | ﹤0.01% |
98,063
-3,400
| -3% | -$94.4K |
2013 Q2
51 quarters
|
|
1707
Getty Realty Corp
GTY
$1.73B
| $2.75M | ﹤0.01% |
86,321
-142,403
| -62% | -$4.45M |
2014 Q2
47 quarters
|
|
1708
MasterCraft Boat Holdings
MCFT
$471M
| $2.74M | ﹤0.01% |
133,456
-4,600
| -3% | -$99.7K |
2021 Q4
17 quarters
|
|
1709
First Financial Bankshares
FFIN
$4.41B
| $2.73M | ﹤0.01% |
92,808
-55,000
| -37% | -$1.73M |
2025 Q4
1 quarter
|
|
1710
AdaptHealth
AHCO
$808M
| $2.72M | ﹤0.01% |
228,373
+21,000
| +10% | +$215K |
2025 Q1
4 quarters
|
|
1711
Neumora Therapeutics
NMRA
$89.4M
| $2.71M | ﹤0.01% |
1,388,998
-56,904
| -4% | -$147K |
2025 Q1
4 quarters
|
|
1712
Preferred Bank
PFBC
$1.22B
| $2.71M | ﹤0.01% |
29,855
-19,900
| -40% | -$1.8M |
2013 Q2
51 quarters
|
|
1713
Alamo Group
ALG
$1.86B
| $2.71M | ﹤0.01% |
16,400
+14,000
| +583% | +$2.64M |
2024 Q2
7 quarters
|
|
1714
PetMed Express
PETS
$27.9M
| $2.7M | ﹤0.01% |
1,186,369
-40,200
| -3% | -$117K |
2013 Q2
51 quarters
|
|
1715
Cardinal Infrastructure Group
CDNL
$453M
| $2.7M | ﹤0.01% |
+68,200
| New | +$1.98M |
2026 Q1
0 quarters
|
|
1716
Eastern Company
EML
$148M
| $2.7M | ﹤0.01% |
133,237
+18,000
| +16% | +$341K |
2013 Q2
51 quarters
|
|
1717
MillerKnoll
MLKN
$1.44B
| $2.69M | ﹤0.01% |
+186,183
| New | +$3.66M |
2026 Q1
0 quarters
|
|
1718
Structure Therapeutics
GPCR
$1.82B
| $2.69M | ﹤0.01% |
55,800
-59,400
| -52% | -$4.07M |
2025 Q1
4 quarters
|
|
1719
Acco Brands
ACCO
$414M
| $2.68M | ﹤0.01% |
894,821
-418,626
| -32% | -$1.58M |
2021 Q4
17 quarters
|
|
1720
Black Rock Coffee Bar Inc
BRCB
$161M
| $2.68M | ﹤0.01% |
207,600
+133,296
| +179% | +$2.16M |
2025 Q4
1 quarter
|
|
1721
Geron
GERN
$787M
| $2.68M | ﹤0.01% |
1,799,521
+1,062,355
| +144% | +$1.61M |
2024 Q4
5 quarters
|
|
1722
Holley
HLLY
$302M
| $2.68M | ﹤0.01% |
873,100
-225,183
| -21% | -$853K |
2023 Q3
10 quarters
|
|
1723
Dimensional US Large Cap Value ETF
DFLV
$7.06B
| $2.67M | ﹤0.01% |
+74,900
| New | +$2.7M |
2026 Q1
0 quarters
|
|
1724
Latham Group
SWIM
$711M
| $2.67M | ﹤0.01% |
497,500
+41,100
| +9% | +$262K |
2022 Q1
16 quarters
|
|
1725
TAL Education Group
TAL
$7.13B
| $2.66M | ﹤0.01% |
+234,200
| New | +$2.64M |
2026 Q1
0 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.